Elkhorn S&P MidCap Health Care Portfolio
XH
XH was delisted on the 14th of September, 2017.
2 hedge funds and large institutions have $737K invested in Elkhorn S&P MidCap Health Care Portfolio in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
52% less capital invested
Capital invested by funds: $1.53M → $737K (-$796K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$927K |
XH Hedge Fund Activity: Q2 2017 in Review
2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Elkhorn S&P MidCap Health Care Portfolio (XH) for Q2 2017, worth a combined $737K — down 52% from $1.53M a quarter earlier.
Fund positioning in XH was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Virtu KCG Holdings, cutting an estimated $927K.
- 2 institutional investors held Elkhorn S&P MidCap Health Care Portfolio (XH) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $737K of Elkhorn S&P MidCap Health Care Portfolio stock for Q2 2017, down 52% quarter-over-quarter.
- 0 funds opened new Elkhorn S&P MidCap Health Care Portfolio positions in Q2 2017 and 0 closed out.
- The largest Elkhorn S&P MidCap Health Care Portfolio seller in Q2 2017 was Virtu KCG Holdings, an estimated $927K sold.
Based on aggregated 13F filings for Q2 2017.